Compare JANX & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JANX | SCHL |
|---|---|---|
| Founded | 2017 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Books |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 790.3M | 842.4M |
| IPO Year | 2021 | 1995 |
| Metric | JANX | SCHL |
|---|---|---|
| Price | $15.18 | $39.75 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 12 | 1 |
| Target Price | ★ $50.09 | $40.00 |
| AVG Volume (30 Days) | ★ 929.9K | 662.1K |
| Earning Date | 05-07-2026 | 03-19-2026 |
| Dividend Yield | N/A | ★ 2.00% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.87 |
| Revenue | $10,000,000.00 | ★ $1,487,100,000.00 |
| Revenue This Year | N/A | $1.75 |
| Revenue Next Year | N/A | $4.23 |
| P/E Ratio | ★ N/A | $21.13 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.12 | $16.03 |
| 52 Week High | $35.34 | $40.15 |
| Indicator | JANX | SCHL |
|---|---|---|
| Relative Strength Index (RSI) | 61.72 | 67.58 |
| Support Level | $13.10 | $27.50 |
| Resistance Level | $15.49 | $39.65 |
| Average True Range (ATR) | 0.57 | 0.59 |
| MACD | 0.09 | -0.08 |
| Stochastic Oscillator | 86.29 | 68.93 |
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.